BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30843345)

  • 1. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
    Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
    J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
    Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
    Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
    Li C; Yang J; Lei S; Wang W
    Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.
    Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX
    J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
    Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
    Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Proliferation by Knockdown of Transmembrane (TMEM) 168 in Glioblastoma Cells via Suppression of Wnt/β-Catenin Pathway.
    Xu J; Su Z; Ding Q; Shen L; Nie X; Pan X; Yan A; Yan R; Zhou Y; Li L; Lu B
    Oncol Res; 2019 Jul; 27(7):819-826. PubMed ID: 30940290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
    Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
    J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway.
    Wang Y; Gao G; Wei X; Zhang Y; Yu J
    Drug Des Devel Ther; 2023; 17():1357-1369. PubMed ID: 37181827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-β-catenin pathway.
    Yu P; Xu T; Ma W; Fang X; Bao Y; Xu C; Huang J; Sun Y; Li G
    J Exp Clin Cancer Res; 2024 Apr; 43(1):116. PubMed ID: 38637831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/β-catenin pathway.
    Wang J; Xia X; Tao X; Zhao P; Deng C
    Bioengineered; 2021 Dec; 12(1):3934-3946. PubMed ID: 34288811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
    Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
    Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal circ-AHCY promotes glioblastoma cell growth via Wnt/β-catenin signaling pathway.
    Li Y; Zheng X; Wang J; Sun M; Li D; Wang Z; Li J; Li Y; Liu Y
    Ann Clin Transl Neurol; 2023 Jun; 10(6):865-878. PubMed ID: 37150844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway.
    Lu F; Li C; Sun Y; Jia T; Li N; Li H
    World J Surg Oncol; 2020 Jun; 18(1):147. PubMed ID: 32605563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma.
    Wang X; Xie X; Zhang Y; Ma F; Pang M; Laster KV; Li X; Liu K; Dong Z; Kim DJ
    Cell Oncol (Dordr); 2022 Feb; 45(1):179-191. PubMed ID: 35102488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDIA6 promotes the proliferation of HeLa cells through activating the Wnt/β-catenin signaling pathway.
    Gao H; Sun B; Fu H; Chi X; Wang F; Qi X; Hu J; Shao S
    Oncotarget; 2016 Aug; 7(33):53289-53298. PubMed ID: 27462866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.
    Han M; Wang S; Fritah S; Wang X; Zhou W; Yang N; Ni S; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
    Brain; 2020 Feb; 143(2):512-530. PubMed ID: 31891366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell proliferation, migration, and invasion by inhibiting the activity of the Wnt/β-catenin signaling pathway.
    Lin H; Shangguan Z; Zhu M; Bao L; Zhang Q; Pan S
    J Cell Biochem; 2019 Jun; 120(6):10625-10632. PubMed ID: 30697812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
    Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
    Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory role of miRNAs on Wnt/β-catenin signaling in tumorigenesis of glioblastoma.
    Rahmani F; Hashemian P; Tabrizi AT; Ghorbani Z; Ziaeemehr A; Alijannejad S; Ferns GA; Avan A; Shahidsales S
    Indian J Cancer; 2023; 60(3):295-302. PubMed ID: 37787188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.